153 related articles for article (PubMed ID: 16255545)
1. [Clinical and economic analysis of the application of ranitidine and famotidine for treatment of duodenal ulcers].
Guseĭnzade MG
Eksp Klin Gastroenterol; 2005; (4):92-101. PubMed ID: 16255545
[No Abstract] [Full Text] [Related]
2. Peptic ulcer disease in adolescence: changing concepts in the age of Helicobacter pylori.
Dominguez HL; Freston JW
Gastroenterologist; 1994 Dec; 2(4):311-4. PubMed ID: 7866738
[No Abstract] [Full Text] [Related]
3. [Pharmacotherapy of non-associated with Helicobacter pylori ulcer].
Grinevich VB; Uspenskiĭ IuP; Shabanova GZh; Sablin OA; Shcherbina NN
Klin Med (Mosk); 2002; 80(10):44-6. PubMed ID: 12471838
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
Belousov IuB; Karpov OI; Belousov DIu; Beketov AS
Ter Arkh; 2007; 79(2):58-66. PubMed ID: 17460971
[No Abstract] [Full Text] [Related]
5. Famotidine in the short and long-term treatment of duodenal ulcer.
Zaterka S; de Paula Castro L; Villalobos JJ; Massuda HK; Eisig JN; Dias Avelar C; Coelho LG; Bettarello A
Acta Gastroenterol Latinoam; 1988; 18(2):115-21. PubMed ID: 3075106
[TBL] [Abstract][Full Text] [Related]
6. [Role of ranitidine in duodenal ulcerous disease].
Mignon M; Fontaine H
Rev Med Suisse Romande; 1995 Oct; 115(10):789-93. PubMed ID: 7501931
[No Abstract] [Full Text] [Related]
7. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
[TBL] [Abstract][Full Text] [Related]
8. Prolonged bedtime treatment with H2-receptor antagonists (ranitidine and famotidine) does not affect blood alcohol levels after ethanol ingestion in male patients with duodenal ulcer.
Casini A; Pizzigallo AM; Mari F; Bertol E; Surrenti C
Am J Gastroenterol; 1994 May; 89(5):745-9. PubMed ID: 8172150
[TBL] [Abstract][Full Text] [Related]
9. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
10. [Famotidine in the therapy and prevention of duodenal ulcer].
Reggio D; Frattaroli FM; Trentino P; Oddi A; Marzullo A; Ponsioen C; Pappalardo G
Clin Ter; 1988 Oct; 127(2):105-11. PubMed ID: 2976345
[No Abstract] [Full Text] [Related]
11. [Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
Maculotti L; Pradella P
Minerva Chir; 1995 Mar; 50(3):279-81. PubMed ID: 7659265
[TBL] [Abstract][Full Text] [Related]
12. [Acute therapy of duodenal ulcer. Comparison of famotidine and ranitidine in a single evening dose].
Kimmig JM
Fortschr Med; 1987 Feb; 105(5):72-6. PubMed ID: 3549493
[No Abstract] [Full Text] [Related]
13. [The comparative efficacy of ranitidine and famotidine in treating exacerbations of duodenal peptic ulcer].
Grigor'ev PIa; Isakov VA; Iakovenko EP
Klin Med (Mosk); 1992; 70(11-12):48-50. PubMed ID: 1294822
[No Abstract] [Full Text] [Related]
14. [Is famotidine--the 3d generation H2 receptor antagonist--a step in progress in the treatment of duodenal ulcer?].
Stasiewicz J; Romatowski J; Kluz A; Szałaj W; Namiot Z
Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1684-6. PubMed ID: 3077455
[No Abstract] [Full Text] [Related]
15. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
[No Abstract] [Full Text] [Related]
16. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer].
Pal'tsev AI; Maslennikova TA
Ter Arkh; 1997; 69(2):62-3. PubMed ID: 9173582
[No Abstract] [Full Text] [Related]
17. [Treatment of duodenal ulcer with famotidine. (Multicenter study)].
Bernal Sahagún F; Barinagarrementería AR; Barrera Ríos L; Briseño Velazco S; Casillas Romo A; Corral Medina A; De la Torre Bravo A; Díaz de León E; Díaz Seoane R; Gallo Reynoso S
Rev Gastroenterol Mex; 1989; 54(1):13-7. PubMed ID: 2667076
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
[No Abstract] [Full Text] [Related]
19. Healing and relapse rates of duodenal ulcer with various H2 receptor antagonists.
Ahmed W; Qureshi H; Zuberi SJ
J Pak Med Assoc; 1988 Dec; 38(12):319-22. PubMed ID: 3148760
[No Abstract] [Full Text] [Related]
20. [Therapeutic management of duodenal ulcer except in emergency cases: antisecretory treatment].
Ruszniewski P
Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S53-S57. PubMed ID: 8734371
[No Abstract] [Full Text] [Related]
[Next] [New Search]
